Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS

v3.20.2
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Total revenues $ 16,021 $ 10,407 $ 71,782 $ 23,031
Costs and expenses:        
Cost of product sales 279 311 434 418
Research and development 14,214 13,226 30,363 24,175
Selling, general and administrative 18,920 18,209 37,350 38,155
Total costs and expenses 33,413 31,746 68,147 62,748
Income (Loss) from operations (17,392) (21,339) 3,635 (39,717)
Interest income 169 733 527 1,513
Interest expense (353)   (495)  
Net income (loss) $ (17,576) $ (20,606) $ 3,667 $ (38,204)
Net income (loss) per share, basic and diluted        
Net income (loss) per share, basic and diluted (in dollars per share) $ (0.10) $ (0.12) $ 0.02 $ (0.23)
Weighted average shares used in computing net income (loss) per share        
Basic (in shares) 168,570 167,191 168,519 167,182
Diluted (in shares) 168,570 167,191 168,525 167,182
Product sales, net        
Total revenues $ 14,974 $ 10,173 $ 27,654 $ 18,227
Contract revenues from collaborations        
Total revenues $ 1,047 $ 234 $ 44,128 $ 4,804